Results 141 to 150 of about 47,365 (201)

Synthesis of PSI Oligosaccharide for the Development of Total Synthetic Vaccine against <i>Clostridium difficile</i>. [PDF]

J Org Chem
Lo HJ, Mettu R, Chen CY, Li ST, Wu CY.
europepmc   +1 more source

Major Systemic Lupus Erythematosus Exacerbation after Severe Clostridium Difficile Infection: A Case Report. [PDF]

Mediterr J Rheumatol
Partalidou S, Katsigianni I, Tara V, Retzeperi E, Radounislis A, Neofytou IE, Valsamidis I, Pehlivanidis A.   +7 more
europepmc   +1 more source

A Two-Stage Cascading Amplification Strategy Based on Zn²⁺-Doped WO_X Nanozymes for Ultrasensitive Lateral Flow Immunoassays of Clostridium Difficile Toxin B. [PDF]

Adv Sci (Weinh)
Su J, Liu Z, Xiong R, Zhu R, Tong Z, Liu Y, Xiao R.   +6 more
europepmc   +1 more source

Loratadine as an Anti-inflammatory Agent Against Clostridium difficile Toxin B. [PDF]

J Infect Dis
Xie Y, Irwin S, Chupina Estrada A, Nelson B, Bullock A, Fontenot L, Feng H, Sun M, Koon HW.   +8 more
europepmc   +1 more source

Environmental and Health Care Personnel Sampling and Unobserved Clostridium difficile Transmission in ICU.

JAMA Netw Open
Keegan LT, Tanner W, Orleans B, Slayton RB, Jernigan JA, McDonald LC, Noble-Wang J, Leecaster M, Haroldsen C, Khader K, Toth DJA, O'Sullivan T, Samore MH, Brazelton W, Rubin M.   +14 more
europepmc   +1 more source

Deadly Diarrhea Caused by Co-Infection of <i>Clostridium perfringens</i> Type ST-865 and <i>Clostridium difficile</i>: A Case Report and Review of the Literature. [PDF]

Infect Drug Resist
Hao Y, Li J, Xie S, Liu Y, Wen H.
europepmc   +1 more source

Clostridium difficile infection in pediatric patients (Review). [PDF]

Biomed Rep
Dop D, Marcu IR, Padureanu V, Caragea DC, Padureanu R, Niculescu SA, Niculescu CE.   +6 more
europepmc   +1 more source

Association between statin administration and <i>Clostridium difficile</i>-induced enteritis: a retrospective analysis of the MIMIC-IV database. [PDF]

Front Pharmacol
Wang R, Liu R, Wang H, Xu Z.
europepmc   +1 more source